Table 2.
Model 1: Leptospirosis case Respondents |
Model 2: Non-leptospirosis case Respondents |
Model 3: Pooled dataset |
||||
---|---|---|---|---|---|---|
Variables | Coeff. | Std. Err. | Coeff. | Std. Err. | Coeff. | Std. Err. |
Random parameters of vaccine attributes in the model | ||||||
EFFICACY of 50-60%a | −2.842*** | 0.318 | −2.157*** | 0.193 | −2.270*** | 0.154 |
EFFICACY of 70-80% | 0.607*** | 0.126 | 0.442*** | 0.079 | 0.479*** | 0.057 |
EFFICACY of 90-100% | 2.235*** | 0.256 | 1.715*** | 0.142 | 1.791*** | 0.127 |
PROTECTION of 2 yearsa | −0.521*** | 0.318 | −0.531*** | 0.077 | −0.500*** | 0.063 |
PROTECTION of 7 years | 0.108 | 0.118 | 0.242*** | 0.065 | 0.144*** | 0.054 |
PROTECTION of 10 years | 0.413*** | 0.116 | 0.289*** | 0.064 | 0.356*** | 0.054 |
SERIOUS RISK of side effectsa | −0.963*** | 0.130 | −0.401*** | 0.075 | −0.559*** | 0.062 |
MODERATE RISK of side effects | 0.337*** | 0.121 | 0.159** | 0.066 | 0.195*** | 0.052 |
MILD RISK of side effects | 0.626*** | 0.129 | 0.242*** | 0.066 | 0.364*** | 0.055 |
Given in 3 SHOTSa | −0.580*** | 0.154 | −0.506*** | 0.129 | −0.453*** | 0.097 |
Given in 2 SHOTS | 0.068 | 0.296 | 0.164 | 0.190 | 0.077 | 0.149 |
Given in 1 SHOT | 0.512*** | 0.188 | 0.342*** | 0.109 | 0.376*** | 0.087 |
Non-random main effects parameters of vaccine attributes in the model | ||||||
Alternative Specific Constant | 2.424*** | 0.994 | 0.255 | 0.476 | 0.317 | 0.395 |
Price | −3.167*** | 0.403 | −3.548*** | 0.251 | −3.291*** | 0.172 |
Socio-demographics & Alternative Specific Constant (ASC) interaction in the modelb | ||||||
AGE*ASC | −0.002 | 0.008 | −0.010** | 0.004 | −0.007 | 0.004 |
EDUCATION*ASC | −0.067 | 0.046 | 0.058** | 0.028 | 0.121 | 0.022 |
FAMILYSIZE*ASC | −0.082 | 0.520 | −0.060** | 0.028 | −0.042 | 0.024 |
INCOME*ASC | 0.015 | 0.011 | 0.012** | 0.012 | 0.010** | 0.004 |
MALE*ASC | 0.121 | 0.422 | 0.200 | 0.199 | 0.527*** | 0.103 |
Living near to a MARKET*ASC | 0.265 | 0.281 | 0.063 | 0.063 | 0.148 | 0.109 |
Living near to a RIVER*ASC | −0.063 | 0.233 | 0.419*** | 0.119 | 0.219** | 0.102 |
Living near to a SEWER*ASC | −0.975*** | 0.282 | −0.232** | 0.118 | −0.314*** | 0.107 |
Leptospirosis AWARNESS*ASC | 1.216** | 0.568 | 0.680*** | 0.235 | 1.040*** | 0.209 |
Derived Standard deviations of the parameter distributions | ||||||
EFFICACY of 70-80% | 0.105 | 9.473 | 0.041 | 3.854 | 0.012 | 0.167 |
EFFICACY of 90-100% | 1.114*** | 0.301 | 0.331 | 0.597 | 0.517 | 0.619 |
PROTECTION of 7 years | 0.070 | 2.414 | 0.004 | 5.776 | 0.006 | 0.168 |
PROTECTION of 10 years | 0.027 | 4.160 | 0.374 | 0.441 | 0.764 | 0.236 |
MODERATE RISK of side effects | 1.080*** | 0.353 | 0.010 | 1.158 | 0.338*** | 0.251 |
MILD RISK of side effects | 0.071 | 2.372 | 0.004 | 4.007 | 0.060 | 0.167 |
Given in 2 SHOTS | 0.443 | 1.407 | 0.009 | 4.906 | 0.011 | 0.232 |
Given in 1 SHOT | 0.209 | 1.384 | 0.968*** | 0.198 | 0.703*** | 0.209 |
Log-likelihood | −865.776 | −2035.251 | −2968.334 | |||
McFadden R2 | 0.424 | 0.323 | 0.342 | |||
No of parameters | 27 | 27 | 27 | |||
χ2 statistics | 1274.252*** | 1941.104*** | 3080.741*** | |||
No of observation | 1368 | 2736 | 4104 |
Notes: ***denotes statistical significance at 1% level and **5% significance level. aBase attribute level. Its coefficient was derived as the negative sum of the coefficients of the other two alternative attribute levels. bThe interaction terms indicate which respondents’ characteristics affect the likelihood of accepting the leptospirosis vaccination program.